Proactive Investors - Run By Investors For Investors

G Medical Innovations appoints expert in health management systems as non-executive director

Professor Zeev Rotstein is an internationally recognised cardiologist and expert in health management systems.
Professor Zeev Rotstein
G Medical is moving ahead towards dual listing on the NASDAQ

G Medical Innovations Holdings Ltd (ASX:GMV) has appointed Professor Zeev Rotstein to the position of non-executive director.

Professor Rotstein is an internationally recognised cardiologist and expert in health management systems, with decades of experience across consultancy and academia.

He is currently serving as the director general, Hadassah Medical Organization; associate clinical professor, The Hebrew University of Jerusalem; and associate clinical professor, Sackler School of Medicine Tel Aviv University.

READ: G Medical Innovations delivers revenue growth; secures first US commercial order

Professor Rostein has acted as an expert consultant in the construction of several medical facilities throughout the world including Centro Medico La Paz, Equatorial Guinea, the Lagoon Hospital, Accra, Ghana and currently the Moscow Medical Cluster Oncological Centre and Polyclinic of Skolkovo, Moscow.

He is trained in medicine at Tel Aviv University, and has held fellowships at the New York Department of Health, Tufts University, and Johns Hopkins Medical Centre School of Hygiene and Public Health.

Professor Rostein joins G Medical as the company farewell Louis Antoniou, president - business development, who has resigned for family reasons.

READ: G Medical Innovations moving towards US public offering and NASDAQ listing

G Medical president and chief executive officer Dr. Yacov Geva said: “We welcome Professor Rotstein to the G Medical Board.

“He brings a wealth of international experience to the company as we accelerate our process towards our dual listing on the NASDAQ.

“We would also like to again thank Louis for his tireless work for the company. He has been an integral team member since the ASX IPO.”

View full GMV profile View Profile

G Medical Innovations Holdings Ltd Timeline

Related Articles

Phone and laptop with images of people and social media graphics
May 29 2019
The company’s business-to-business social network is the fastest growing digital marketing, e-commerce platform in the cannabis industry
An armour plate based on XTclave technology
April 28 2019
The upper limit of the defence supplier’s guidance this half-year is $21.6 million.
ROBO Global US CEO Travis Briggs
August 14 2018
Investors can buy directly into the popular ROBO ETF based on the benchmark index comprised of 87 top robotics, automation and AI companies.
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use